Elunate (Fruquintinib)

Elunate (fruquintinib) is a kinase inhibitor used for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.

Recommended Dosage:
The recommended dose of Fruquintinib is 5 mg once daily, for 3 consecutive weeks, followed by 1 week of a drug-free period (Every 4 weeks as one treatment cycle). The dosage may be taken orally with food or on an empty stomach, and it must be swallowed whole. It is recommended to take all the doses at the same time each day.
In case the patient vomits after administering the medicine, there is no requirement to make up for the dose; in case a dose is missed, instruct the patient not to make up for the dose the next day, but to take the very next dose at its next scheduled time.

• Treatment with Fruquintinib 1 mg/5 mg capsules may be responsible for increasing blood pressure. Monitor blood pressure frequently during treatment. Start or adjust anti-hypertensive therapy in case required. Uncontrolled high blood pressure may cause serious complications, so let your doctor know about any known history of hypertension before starting this treatment.
• Bleeding may occur while using this therapeutic drug, including serious or fatal hemorrhages. Patients with tumors near blood vessels are at greater risk. Do not use it with other blood-thinning medicines. Report unusual bruising, bleeding, or blood in stool or urine to your doctor quickly.
• This medicinal product can increase infection risk because of its influence on immunity. Monitor for fever, sore throat, or other indications of infection. Get medical help quickly if symptoms occur. Do not go to crowded places or have close contact with sick people during treatment to decrease exposure.
• Serious gastrointestinal perforations may occur with this medicine. Symptoms may include nausea, severe abdominal pain, or fever. Stop treatment quickly and seek emergency care if perforation is suspected. Patients with known bowel conditions must be monitored closely during treatment.
• Liver complications can develop while using this medicine. Monitor liver enzymes and bilirubin before and while on treatment. Let your doctor know about your liver disease history. Stop or adjust the dose if significant liver injury occurs. Symptoms include dark urine, fatigue, and yellowing of skin or eyes.
• Therapy with Fruquintinib 1 mg/5 mg capsules may cause protein to leak into the urine. Routine urine tests are required. Serious cases may require dose reduction or treatment interruption. Report any signs and symptoms like swelling in the legs or foamy urine, as they could be signs of worsening kidney function.
• This condition may cause swelling, redness, pain, or blisters on the hands and feet. It affects quality of life and may require dose modification. Use moisturizers, wear loose shoes, and avoid hot water. Let your doctor know early if symptoms worsen or become very painful.
  This medicine may delay wound healing. Do not start treatment before or soon after major surgery. Wait at least 14 days after surgical procedures unless approved by your clinician. Let your physician know about any planned surgeries or non-healing wounds before continuing treatment.
• Events like a stroke or a heart attack may happen. Patients with known cardiovascular disease are at greater risk. Monitor for shortness of breath, chest pain, or limb weakness. Get immediate care in case such symptoms occur. Caution must be used in elderly or high-risk patients.
• Fruquintinib may cause harm to an unborn baby. Avoid using during pregnancy. Women of childbearing age must use appropriate birth control during treatment and for some time after the final dose. Let your doctor know immediately in case you become pregnant during or after treatment.
• It is not known whether this medicine passes into human breast milk. Because of potential harm to a nursing infant, breastfeeding is not recommended during treatment and for a period after stopping the medicine. Consult your healthcare provider (HCP) to weigh risks and benefits.

What documents are required to import ELUNATE to India?

ELUNATE (fruquintinib) capsules can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product.

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is ELUNATE available in India?

ELUNATE (fruquintinib capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Elunate in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

ELUNATE can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ELUNATE (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Elunate 1 mg/5 mg Capsule price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ELUNATE (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Elunate®?

Fruquintinib is the Generic Name for the trade name drug Elunate®.

What is the Manufacturer’s Name of Elunate®?

Elunate® is manufactured by Hutchmed Ltd.

Is Elunate® approved by the FDA?

Fruquintinib was approved by the China National Medical Products Administration (NMPA) in September 2018 under the brand name ELUNATE®. Fruquintinib (FRUZAQLA® outside China) was approved by the FDA in November 2023, by the European Commission in June 2024, and in 10 other countries.

What is the dosage and form of Elunate® supplied?

Elunate is supplied in Capsules: 1 mg and 5 mg for oral administration.

What are the most common side effects of Elunate® 1 mg/5 mg Capsule?

The most common side effects of Elunate® are hypertension, diarrhea, palmar-plantar erythrodysesthesia, dysphonia, abdominal pain, proteinuria, and asthenia.

How much does Elunate® 1 mg/5 mg Capsule cost in India?

Prices of Elunate Capsules may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Elunate 1 mg/5 mg cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Elunate® 1 mg/5 mg Capsules be available in SAARC countries?

Apart from Gulf countries, Elunate® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Elunate® capsules in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Elunate® 1 mg/5 mg Capsule online in India?

Yes, one can buy Elunate 1 mg/5 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Elunate® Capsule through legal channels.

What are the storage conditions of Elunate® 1 mg/5 mg Capsules?

Store the bottle of this therapeutic drug at 20°C to 25°C (68°F to 77°F). Brief exposure to 15°C and 30°C (59°F to 86°F).